The Israeli institute will share its expertise on translating research into commercially viable applications with the goal of advancing personalized medicine.
Researchers are developing a nanopore sensing device that relies on restriction enzymes to target specific clinically relevant variants in pathogens.
Technion's Reut Shalgi is building up her lab to study how chaperones affect protein synthesis and protein folding.
The majority of the funding will be used to establish a cancer metabolomics research center on Technion's campus.
An Australian-led team has generated a draft genome assembly of the invasive cane toad in hopes it will help in population control, the Sydney Morning Herald reports.
The New York Times reports that the US Department of Defense has implemented about half the recommendations made to improve safe handling of dangerous agents.
In PLOS this week: approach for teasing out archaic introgression in human genomes, immune transcription features in HCV infection, and more.
Stat News reports that Maryland is promoting itself to the biotech industry with a mobile billboard.